S&P 500   3,249.22 (-2.65%)
DOW   28,191.04 (-2.76%)
QQQ   222.91 (-3.20%)
AAPL   299.91 (-4.20%)
FB   201.22 (-4.26%)
MSFT   172.95 (-3.16%)
GOOGL   1,427.82 (-3.75%)
AMZN   2,005.69 (-4.31%)
NVDA   279.27 (-5.03%)
BABA   205.53 (-3.32%)
MU   54.73 (-3.97%)
GE   11.97 (-2.37%)
TSLA   843.50 (-6.38%)
AMD   49.79 (-6.55%)
T   38.26 (-0.75%)
ACB   1.57 (-5.99%)
F   7.65 (-3.17%)
NFLX   370.18 (-2.60%)
PRI   127.75 (-3.46%)
BAC   32.92 (-4.19%)
DIS   131.96 (-5.04%)
GILD   72.87 (+4.55%)
S&P 500   3,249.22 (-2.65%)
DOW   28,191.04 (-2.76%)
QQQ   222.91 (-3.20%)
AAPL   299.91 (-4.20%)
FB   201.22 (-4.26%)
MSFT   172.95 (-3.16%)
GOOGL   1,427.82 (-3.75%)
AMZN   2,005.69 (-4.31%)
NVDA   279.27 (-5.03%)
BABA   205.53 (-3.32%)
MU   54.73 (-3.97%)
GE   11.97 (-2.37%)
TSLA   843.50 (-6.38%)
AMD   49.79 (-6.55%)
T   38.26 (-0.75%)
ACB   1.57 (-5.99%)
F   7.65 (-3.17%)
NFLX   370.18 (-2.60%)
PRI   127.75 (-3.46%)
BAC   32.92 (-4.19%)
DIS   131.96 (-5.04%)
GILD   72.87 (+4.55%)
S&P 500   3,249.22 (-2.65%)
DOW   28,191.04 (-2.76%)
QQQ   222.91 (-3.20%)
AAPL   299.91 (-4.20%)
FB   201.22 (-4.26%)
MSFT   172.95 (-3.16%)
GOOGL   1,427.82 (-3.75%)
AMZN   2,005.69 (-4.31%)
NVDA   279.27 (-5.03%)
BABA   205.53 (-3.32%)
MU   54.73 (-3.97%)
GE   11.97 (-2.37%)
TSLA   843.50 (-6.38%)
AMD   49.79 (-6.55%)
T   38.26 (-0.75%)
ACB   1.57 (-5.99%)
F   7.65 (-3.17%)
NFLX   370.18 (-2.60%)
PRI   127.75 (-3.46%)
BAC   32.92 (-4.19%)
DIS   131.96 (-5.04%)
GILD   72.87 (+4.55%)
S&P 500   3,249.22 (-2.65%)
DOW   28,191.04 (-2.76%)
QQQ   222.91 (-3.20%)
AAPL   299.91 (-4.20%)
FB   201.22 (-4.26%)
MSFT   172.95 (-3.16%)
GOOGL   1,427.82 (-3.75%)
AMZN   2,005.69 (-4.31%)
NVDA   279.27 (-5.03%)
BABA   205.53 (-3.32%)
MU   54.73 (-3.97%)
GE   11.97 (-2.37%)
TSLA   843.50 (-6.38%)
AMD   49.79 (-6.55%)
T   38.26 (-0.75%)
ACB   1.57 (-5.99%)
F   7.65 (-3.17%)
NFLX   370.18 (-2.60%)
PRI   127.75 (-3.46%)
BAC   32.92 (-4.19%)
DIS   131.96 (-5.04%)
GILD   72.87 (+4.55%)
Log in

ProPhase Labs SEC Filings & 10K Form (NASDAQ:PRPH)

$1.74
0.00 (0.00 %)
(As of 02/24/2020 11:20 AM ET)
Today's Range
$1.74
Now: $1.74
$1.75
50-Day Range
$1.74
MA: $1.85
$1.98
52-Week Range
$1.63
Now: $1.74
$3.36
Volume426 shs
Average Volume1,715 shs
Market Capitalization$20.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07

SEC Filings

ProPhase Labs (NASDAQ:PRPH) SEC Filings

DateFilerForm TypeView
01/03/2020
8:07 PM
Barr Jason Michael (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:05 PM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
3:15 PM
Hirsch Warren (Reporting)
ProPhase Labs (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2019
3:15 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
3:20 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
2:54 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/03/2019
5:44 PM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
5:42 PM
Barr Jason Michael (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:00 PM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:00 PM
Barr Jason Michael (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
2:53 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2019
7:30 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
6:00 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
3:15 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
3:31 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/04/2019
5:07 PM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
3:46 PM
ProPhase Labs (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2019
7:15 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
6:40 PM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
6:15 PM
Brady Monica L. (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2018
1:04 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/21/2018
5:15 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2018
4:06 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/20/2018
3:55 PM
ProPhase Labs (Filer)
Form 10-Q/A
08/20/2018
3:52 PM
ProPhase Labs (Filer)
Form 10-K/A
08/20/2018
3:48 PM
ProPhase Labs (Filer)
Form 10-Q/A
08/20/2018
3:46 PM
ProPhase Labs (Filer)
Form 10-Q/A
08/20/2018
3:44 PM
ProPhase Labs (Filer)
Form 10-Q/A
08/14/2018
7:06 PM
ProPhase Labs (Filer)
Form NT 10-Q
07/23/2018
9:09 AM
GLECKEL LOUIS MD (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2018
9:08 AM
Burnett Mark A. (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
11:15 PM
ProPhase Labs (Filer)
Form EFFECT
06/25/2018
4:31 PM
ProPhase Labs (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2018
3:06 PM
ProPhase Labs (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/17/2018
11:40 AM
Karkus Ted William (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2018
2:19 PM
ProPhase Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2018
8:40 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
5:25 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
1:27 PM
ProPhase Labs (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/19/2018
9:20 AM
ProPhase Labs (Filer)
Form DEF 14A
04/16/2018
3:13 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2018
3:47 PM
ProPhase Labs (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/23/2018
5:01 AM
ProPhase Labs (Filer)
Form DEF 14A
03/22/2018
2:47 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2018
3:06 PM
ProPhase Labs (Filer)
Form PRE 14A
02/26/2018
3:23 PM
Karkus Ted William (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2018
3:21 PM
Karkus Ted William (Filed by)
ProPhase Labs (Subject)
Form SC 13D/A
02/21/2018
5:15 AM
ProPhase Labs (Filer)
Form 15-12G
02/21/2018
5:14 AM
ProPhase Labs (Filer)
Form 8-A12G/A
02/21/2018
5:05 AM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2018
4:19 PM
BML Investment Partners, L.P. (Filed by)
ProPhase Labs (Subject)
Form SC 13G/A
12/26/2017
2:08 PM
Karkus Ted William (Filed by)
ProPhase Labs (Subject)
Form SC 13D/A
12/26/2017
2:02 PM
Karkus Ted William (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2017
3:26 PM
ProPhase Labs (Filer)
Form 8-K/A
12/21/2017
3:24 PM
ProPhase Labs (Subject)
Form SC TO-I/A
12/19/2017
4:21 PM
ProPhase Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2017
4:20 PM
ProPhase Labs (Subject)
Form SC TO-I/A
12/18/2017
3:00 PM
Karkus Ted William (Reporting)
ProPhase Labs (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel